RobbinsSLCotranR.Pathologic basis of disease. Philadelphia: WB Saunders, 1979: 1004, 1189–90.
2.
DohertyCCMcGeownMGDonaldsonRA, Retroperitoneal fibrosis after treatment with atenolol (letter). Br Med J1978; 2: 1786.
3.
JohnsonJNMcFarlandJ.Retroperitoneal fibrosis associated with atenolol (letter). Br Med J1980: 280: 864.
4.
McCluskeyDRDonaldsonRAMcGeownMG, Oxprenolol and retroperitoneal fibrosis. Br Med J1980; 281: 1459–60.
5.
ThompsonJ.JulianDG, Retroperitoneal fibrosis associated with metoprolol. Br Med J1982; 284: 83–4.
6.
RimmerE.RichensA.ForsterME., Retroperitoneal fibrosis associated with timolol (letter). Lancet1983; 1: 300.
7.
HenriL.GroleauM.Retroperitoneal fibrosis after treatment with propranolol. Drug Intell Clin Pharm1981; 15: 696.
8.
PierceJRJrTrostleDCWarnerJJ, Propranolol and retroperitoneal fibrosis (letter). Ann Intern Med1981; 95: 244.
9.
MitchinsonMJ, Retroperitoneal fibrosis associated with metoprolol (letter). Br Med J1982; 284: 347.
10.
AsburyMJ, Retroperitoneal fibrosis after treatment with atenolol (letter). Br Med J1979; 1: 492.
11.
GavinMJCastleWMCruickshankJM., Retroperitoneal fibrosis associated with atenolol (letter). Br Med J1980; 280: 1227–8.
12.
MundyARKinderCHFlanneryJF., Hypertension and thromboembolism in idiopathic retroperitoneal fibrosis. Br J Urol1982; 54: 625–7.
13.
CruickshankJM, How safe are β-blockers. Drugs1983; 25 (suppl 2): 331–40.
14.
CastleWMCruickshankJMWaycottJA, Retroperitoneal fibrosis associated with atenolol (letter). Br Med J1980; 281: 311.
15.
BullimoreDW, Retroperitoneal fibrosis associated with atenolol (letter). Br Med J1980; 281: 564.
16.
PryorJPCastleWMDukesDCSmithJCWatsonMEWilliamsJL, Do beta-adrenoceptor blocking drugs cause retroperitoneal fibrosis? Br Med J1983; 287: 639–41.
17.
DavisHWGartnerJCGalvisAGMichaelsRHMestadPH, Acute upper airway obstruction: Group and epiglottitis. Pediatr Clin North Am1981; 28: 859–80.
18.
CherryJD, The treatment of croup; continued controversy due to failure of recognition of historic, écologic, etiologic and clinical perspectives. J Pediatr1979; 94: 352–4.
19.
DennyFWMurphyTFClydeWACollierAMHendersonFW, Croup: An 11-year study in a pediatric practice. Pediatrics1983; 71: 871–6.
KonigP.The relationship between croup and asthma. Ann Allergy1978; 41: 227–31.
22.
TunnessenWWFeinsteinAR, The steroid-croup controversy: An analytic review of méthodologic problems. J Pediatr1980; 96: 751–6.
23.
JamesJA, Dexamethasone in croup. Am J Dis Child1969; 117: 511–6.
24.
LeipzigB.OskiFACummingsCSStockmanJASwenderP.A prospective randomized study to determine the efficacy of steroids in treatment of croup. J Pediatr1979; 94: 194–6.
25.
MassicotteP.TetreaultL.Evaluation de la methylprednisolone dans le traitement des laryngites aigues de l'enfant. Union Med Can1973; 102: 2064–89.
26.
HawkinsDB, Corticosteroids in the management of laryngotracheobronchitis. Otolaryngol Head Neck Surg1980; 88: 207–10.
27.
MelbyJC, Systemic corticosteroid therapy: Pharmacology and endocrinologie considerations. Ann Intern Med1974; 81: 505–12.
28.
WesselyK.Weitere Beitrage zun Lehre vom Augendruck. Arch Augenheilkd1915; 78: 247.
29.
WizemannAJSWizemannV.Organic nitrate therapy in glaucoma. Am J Ophthalmol1980; 90: 106–9.
30.
WhitworthCGGrantWM, Use of nitrate and nitrate vasodilators by glaucomatous patients. Arch Ophthalmol1964; 71: 492–6.
31.
WiszniaKILazarM.LeopoldIH, Oral isosorbide and intraocular pressure. Am J Ophthalmol1970; 70: 630–4.
32.
RobertsonD.StevensRM, Nitrates and glaucoma (letter). JAMA1977; 237: 117.
